$EAR is giving a GREAT IPO LONG opportunity todayIPO intraday trading strategy idea
Eargo makes hearing aids.
The share price is rising and gonna continue this trend today.
The demand for shares of the company still looks higher than the supply.
These and other conditions can cause a rise in the share price today.
So I opened a long position from $39,00;
stop-loss — $33,30;
take-profit — $56,10.
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
IPO
$PRAX is giving a GREAT IPO LONG opportunity todayIPO intraday trading strategy idea
Praxis Precision Medicinesis is a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system disorders characterized by a neuronal imbalance.
The share price is rising and gonna continue this trend today.
The demand for shares of the company still looks higher than the supply.
These and other conditions can cause a rise in the share price today.
So I opened a long position from $27,50;
stop-loss — $24,23;
take-profit — $37,31.
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
$ARRY is giving a GREAT IPO LONG opportunity todayIPO intraday trading strategy idea
Array makes solar trackers, which move panels during the day to maintain optimal orientation to the sun.
The share price is rising and gonna continue this trend today.
The demand for shares of the company still looks higher than the supply.
These and other conditions can cause a rise in the share price today.
So I opened a long position from $30,30;
stop-loss — $28,10;
take-profit — $36,90.
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
Potential IPO base $LMNDPotential IPO base
"90 seconds to get insured. 3 minutes to get paid"
If you haven't already noticed, we are living in a world of immediate gratification. Insurance is just another sector that's ripe to be disrupted by better efficiency.
TA,
- Increasing volume and consolidating at previous highs $69.
FA,
- Disrupting the archaic industry of insurance
-High NPS score of 70. Industry average is 70.
- $5 Trillion TAM. Current market cap is $3.8Bn
- Huge barrier between insurance companies and customers. Making claims is a headache. Lemonade is bridging that gap through better customer service by leveraging the powers of AI. AI JIM and AI MAYA
- +167% revenue growth 2020
- Expansion beyond US. France is next by end of 2020.
- Only 3 types available still. Renters, home and pet insurance. More potential for other types
Concerns,
- Still not fully convinced of the business model
-Continued losses(side effect of disrupting)
- Price discovery phase still so will be super volatile.
Entry : Break of 69.2
Stop loss: 62.2
Deal °157 IPO Ergo (EAR) +350000 RUB on hearing AIDS!Stock market. Stocks. IPO Eargo (EAR) — on October 15, 2020, the IPO of a company that is a manufacturer of medical equipment for people with hearing loss will take place. J. P. Morgan and BofA Securities are the underwriters of the offering… The deadline for submitting an order with the broker is 20-00 Moscow time on 14.10.2020, the start date of trading is 16.10.2020.
2% of the Fund will be invested in shares of this company. A detailed report on the transaction, or "opportunity card", for all partners of our Fund will be provided in PDF format. Anyone who wants to get more information, please write in private messages.
PLTR recent IPOI like the hammer candle ok and it is forming a nice retest of that gap off of the big up day. Gave it a little extra wiggle room because it is a new name.
Deal ✓152 - IPO Array - solar powered +$ 5,000 per day!Stock market. Stocks. IPO Array Technologies (ARRY) — on October 14, 2020, the IPO of Array Technologies will take place. The company is one of the world's largest manufacturers of ground — mounted systems for solar energy projects-solar trackers. The placement is underwritten by Goldman Sachs, JPMorgan, Guggenheim Securities and Morgan Stanley. The deadline for submitting an order with the broker is until 20-00 Moscow time on 13.10.2020, the start date of trading is 15.10.2020.
2% of the Fund will be invested in shares of this company. A detailed report on the transaction, or "opportunity card", for all partners of our Fund will be provided in PDF format. Anyone who wants to get more information, please write in private messages.
Keywords: IPO, opportunity, insider, profit
$IH is giving a GREAT IPO LONG opportunity todayIPO intraday trading strategy idea
iHuman provides an online childhood edutainment destination for children in China.
The share price is rising and gonna continue this trend today.
The demand for shares of the company still looks higher than the supply.
These and other conditions can cause a rise in the share price today.
So I opened a long position from $13,12;
stop-loss — $11,55;
take-profit — $17,83.
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
🌀 Deal ✓141 - IPO of Spruce Biosciences (SPRB) another biotech!Stock market. Stocks. IPO of Spruce Biosciences (SPRB) — on October 09, 2020, shares of a Company developing new treatments for rare endocrine diseases will start trading on the American stock exchange. The placement is underwritten by Cowen, SVB Leerink, Credit Suisse and RBC Capital Markets. The deadline for submitting an application with the broker is 20-00 Moscow time 07.10.2020, the placement date is 08.10.20
2% of the Fund will be invested in shares of this company. A detailed report on the transaction, or "opportunity card", for all partners of our Fund will be provided in PDF format. Anyone who wants to receive them is asked to write with private messages.
Company: Spruce Biosciences, Inc. (SPB) boutique
rating: 3
Scoop rating: 2
Oversubscribed: oversubscribed (100% )
LONG CITRON is giving a GREAT LONG opportunity with $CMPSCitron following intraday trading strategy idea
COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States.
The share price is rising and gonna continue this trend today after the new Citron report publishing.
The demand for shares of the company still looks higher than the supply.
These and other conditions can cause a rise in the share price today.
So I opened a long position from $41,92;
take-profit — $51,88;
stop-loss — $38,59
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
Thanks for being with me!
CMPS IPO LTBHIPO long term buy and hold following analysis from a trusted expert source.
5-10 year timeframe.
See chart annotations for entry.
Position size 1% of account as usual.
$PLTR is giving a GREAT IPO LONG opportunity todayIPO intraday trading strategy idea
Palantir Technologies is a data analytics software company.
The share price is rising and gonna continue this trend today.
The demand for shares of the company still looks higher than the supply.
These and other conditions can cause a rise in the share price today.
So I opened a long position from $11,13;
stop-loss — $9,71;
take-profit — $15,39 or MOC price.
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
$CD is giving a GREAT IPO LONG opportunity todayIPO intraday trading strategy idea
Chindata Group Holdings builds and operates hyper-scale data centers in China, Malaysia, and soon in India.
The share price is rising and gonna continue this trend today.
The demand for shares of the company still looks higher than the supply.
These and other conditions can cause a rise in the share price today.
So I opened a long position from $14,66;
stop-loss — $13,66;
take-profit — 17,66.
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
$ASAN is giving a GREAT IPO LONG opportunity todayIPO intraday trading strategy idea
Asana is a work management company.
The share price is rising and gonna continue this trend today.
The demand for shares of the company still looks higher than the supply.
These and other conditions can cause a rise in the share price today.
So I opened a long position from $29,37;
stop-loss — $26,63
take-profit — MOC price
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
$AVO is giving a GREAT IPO LONG opportunity todayIPO intraday trading strategy idea
Mission Produce is a world leader in sourcing, producing, and distributing fresh avocados, servicing retail, wholesale, and foodservice customers in over 25 countries.
The share price is rising and gonna continue this trend today.
The demand for shares of the company still looks higher than the supply.
These and other conditions can cause a rise in the share price today.
So I opened a long position from $13,45;
stop-loss — $11,82;
take-profit — $18,34.
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
2000 vs 20201. Record IPO year
2. Bankruptcies
3. Tech bubble
4. Retail is all in
5. Massive unemployment worldwide
Is history repeating? Let's see in the following month
Deal 115 - IPO 4 Therapeutics (CCCC) -money for cancer treatmentStock market. Stocks. IPO of C4 Therapeutics (CCC) — October 02, 2020 will start trading on the US NASDAQ stock exchange for the company that develops new cancer treatments by using the natural regulation of protein in the body. The placement is underwritten by Jefferies, Evercore ISI, BMO Capital Markets and UBS Investment Bank. The deadline for submitting an application with the broker is 20-00 Moscow time 30.09.2020, the placement date is 01.10.2020.
2% of the Fund will be invested in shares of this company. A detailed report on the transaction, or "opportunity card", for all partners of our Fund will be provided in PDF format. Anyone who wants to receive them is asked to write with private messages.
$PRLD is giving a GREAT IPO LONG opportunity todayIPO intraday trading strategy idea
Prelude Therapeutics is a clinical-stage biopharma developing treatments for various cancers.
The share price is rising and gonna continue this trend today.
The demand for shares of the company still looks higher than the supply.
These and other conditions can cause a rise in the share price today.
So I opened a long position from $26,25;
stop-loss — $22,94;
take-profit — $36,18.
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
AMST: Decent IPO EntryAny entry for AMST under $5.50 I believe is decent. I think the stock is poised to go up and garnish some major support levels. Current target is at 115% current price. It is mid to high risk for an IPO surge, but I feel like the support level patterns at open usually follows that of the IPOs expected to garnish surge support. That being said, do your own due diligence and invest at your own risk. Consider everything I say on the basis of opinion.
$BSY is giving a GREAT IPO LONG opportunity todayIPO intraday trading strategy idea
Bentley Systems provides infrastructure engineering software to clients worldwide.
The share price is rising and gonna continue this trend today.
The demand for shares of the company still looks higher than the supply.
These and other conditions can cause a rise in the share price today.
So I opened a long position from $29,77;
stop-loss — $25,77;
take-profit — $41,77.
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
$GDRX is giving a GREAT IPO LONG opportunity todayIPO intraday trading strategy idea
GoodRx is a platform for prescription price comparison and negotiating with pharmacy benefits managers (PBM) to receive cost-savings for its users.
The share price is rising and gonna continue this trend today.
The demand for shares of the company still looks higher than the supply.
These and other conditions can cause a rise in the share price today.
So I opened a long position from $49,5;
stop-loss — $45,5;
take-profit — $61,5.
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
🌀 Attention! Deal °86 IPO Prelude T. - for cancer treatment!Stock market. Stocks. IPO Prelude Therapeutics — (PRLD) - September 25, 2020 on the American stock exchange will begin trading shares of the company (the deadline for submitting an application for participation with a broker is 20-00 Moscow time on 23.09.2020), which develops drugs for the treatment of cancer. The placement is underwritten by Morgan Stanley, Goldman Sachs and Bofasecuries. Company: Prelude Therapeutics (PLC) is a boutique Rating: 3 stars out scoop: 2 Oversubscription: 100% Allocation: up to 20%
2% of the Fund will be invested in shares of this company. Detailed reports on our paid subscription for all partners will be provided in PDF (additional data on request in PM)
